Total Clarity Wealth Management, Inc. Iovance Biotherapeutics, Inc. Transaction History

Total Clarity Wealth Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$12.38 - $19.1 $6,895 - $10,638	-557 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$20.35 - $26.63 $11,334 - $14,832	557 New	557 $14,000
Q2 2021 Jul 26, 2021	SELL	$16.33 - $33.07 $30,978 - $62,733	-1,897 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$28.67 - $52.59 $54,386 - $99,763	1,897 New	1,897 $60,000
Q1 2020 Apr 24, 2020	SELL	$19.54 - $38.85 $6,252 - $12,432	-320 Closed	0 $0
Q4 2019 Feb 27, 2020	BUY	$17.95 - $29.41 $5,744 - $9,411	320 New	320 $9,000

313

237M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.17B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.